Uncover how AI in Drug Discovery is revolutionising pharmaceutical research, enhancing predictive modelling, and streamlining clinical trials.
Scott Dylan is Dublin based British entrepreneur, investor, and mental health advocate. He is the Founder of NexaTech Ventures, a venture capital firm with a £100 million fund supporting AI and technology startups across Europe and beyond. With over two decades of experience in business growth, turnaround, and digital innovation, Scott has helped transform and invest in companies spanning technology, retail, logistics, and creative industries.
Beyond business, Scott is a passionate campaigner for mental health awareness and prison reform, drawing from personal experience to advocate for compassion, fairness, and systemic change. His writing explores entrepreneurship, AI, leadership, and the human stories behind success and recovery.